相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Anna Tjarnlund et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis
Rohit Aggarwal et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy
Minoru Satoh et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort
Niharika Sharma et al.
JOURNAL OF RHEUMATOLOGY (2017)
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E. Lundberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Myositis-specific autoantibodies: an important tool to support diagnosis of myositis
Z. Betteridge et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease
Dong Jin Go et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases
Patrick Cherin et al.
AUTOIMMUNITY REVIEWS (2016)
Spectrum of immune-mediated necrotizing myopathies and their treatments
Iago Pinal-Fernandez et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Recent advances in dermatomyositis-specific autoantibodies
Manabu Fujimoto et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis
Ken-ichi Ueno et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response
Jutta Bauhammer et al.
JOURNAL OF RHEUMATOLOGY (2016)
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
Nicolino Ruperto et al.
LANCET (2016)
Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases
Fabian Speth et al.
PEDIATRIC RHEUMATOLOGY (2016)
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease
Leah J. Witt et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Rituximab in autoimmune connective tissue disease-associated interstitial lung disease
Charles Sharp et al.
RHEUMATOLOGY (2016)
Power Doppler Ultrasonography for Detection of Increased Vascularity in the Fascia: A Potential Early Diagnostic Tool in Fasciitis of Dermatomyositis
Ken Yoshida et al.
Arthritis & Rheumatology (2016)
Corticosteroid Monotherapy Is Usually Insufficient Treatment for Idiopathic Inflammatory Myopathy
Tanisha Mathur et al.
AMERICAN JOURNAL OF THERAPEUTICS (2015)
Pulse Dose Methylprednisolone Therapy for Adult Idiopathic Inflammatory Myopathy
Padmanabhan Raghu et al.
AMERICAN JOURNAL OF THERAPEUTICS (2015)
Multitarget Therapy for Induction Treatment of Lupus Nephritis A Randomized Trial
Zhihong Liu et al.
ANNALS OF INTERNAL MEDICINE (2015)
The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review
Yongpeng Ge et al.
CLINICAL RHEUMATOLOGY (2015)
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis
David F. Fiorentino et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis
Yusuke Yokoyama et al.
MODERN RHEUMATOLOGY (2015)
Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
Helena Andersson et al.
RHEUMATOLOGY (2015)
Use of rituximab in histologically confirmed idiopathic inflammatory myositis: a case series
Chaminda Basnayake et al.
CLINICAL RHEUMATOLOGY (2015)
The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis
T. Kurita et al.
LUPUS (2015)
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti-Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
Yves Allenbach et al.
PLOS ONE (2015)
The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis
Takashi Kurita et al.
RHEUMATOLOGY (2015)
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids
Fowzia Ibrahim et al.
RHEUMATOLOGY (2015)
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up
Mei Zong et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis
Maria Giovanna Danieli et al.
CLINICAL RHEUMATOLOGY (2014)
Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis
Eizo Saito et al.
Modern Rheumatology (2014)
Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial
Nobuyuki Miyasaka et al.
Modern Rheumatology (2014)
Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population
Leonore Unger et al.
RHEUMATOLOGY (2014)
Pilot Study of Etanercept in Patients With Refractory Juvenile Dermatomyositis
Kelly A. Rouster-Stevens et al.
ARTHRITIS CARE & RESEARCH (2014)
Predictors of Clinical Improvement in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis
Rohit Aggarwal et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Cyclosporine in Anti-Jo1-positive Patients with Corticosteroid-refractory Interstitial Lung Disease
Lorenzo Cavagna et al.
JOURNAL OF RHEUMATOLOGY (2013)
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study
Michalis L. Kosmidis et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
Lisa G. Rider et al.
MEDICINE (2013)
Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: a study of fourteen cases and literature review
Dan Chen et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Autoantibodies in Polymyositis and Dermatomyositis
Anna Ghirardello et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/dermatomyositis: a retrospective study
Yasuhiro Shimojima et al.
BMC MUSCULOSKELETAL DISORDERS (2012)
Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature
Shiro Matsubara et al.
CLINICAL RHEUMATOLOGY (2012)
Myositis autoantibodies
Livia Casciola-Rosen et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Long-Term Outcome of Polymyositis Treated with High Single-Dose Alternate-Day Prednisolone Therapy
Makoto Uchino et al.
EUROPEAN NEUROLOGY (2012)
Mycophenolate mofetil in juvenile dermatomyositis: a case series
Rawane Dagher et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
Todd Levine
DRUG DESIGN DEVELOPMENT AND THERAPY (2012)
Etanercept as Steroid-Sparing Agent in Dermatomyositis Reply
Anthony A. Amato
ANNALS OF NEUROLOGY (2011)
Efficacy of intravenous Ig therapy in juvenile dermatomyositis
Catherine G. Lam et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis A Multicenter Cross-sectional Study
Yasuhito Hamaguchi et al.
ARCHIVES OF DERMATOLOGY (2011)
Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase in Patients With Statin-Associated Autoimmune Myopathy
Andrew L. Mammen et al.
ARTHRITIS AND RHEUMATISM (2011)
Safety and Efficacy of Rituximab in Severe Juvenile Dermatomyositis: Results from 9 Patients from the French Autoimmunity and Rituximab Registry
Brigitte Bader-Meunier et al.
JOURNAL OF RHEUMATOLOGY (2011)
Fasciitis as a Common Lesion of Dermatomyositis, Demonstrated Early After Disease Onset by En Bloc Biopsy Combined With Magnetic Resonance Imaging
Ken Yoshida et al.
ARTHRITIS AND RHEUMATISM (2010)
Evaluation of the effectiveness of treatment with rituximab associated to cyclophosphamide in patients with resistant idiopathic inflammatory myopathy
Francisco Jose Garcia Hernandez et al.
MEDICINA CLINICA (2010)
Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial
J. van de Vlekkert et al.
NEUROMUSCULAR DISORDERS (2010)
Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis
Pamela A. Morganroth et al.
ARTHRITIS CARE & RESEARCH (2010)
Mycophenolate Mofetil: A Possible Therapeutic Agent for Children With Juvenile Dermatomyositis
Kelly A. Rouster-Stevens et al.
ARTHRITIS CARE & RESEARCH (2010)
Intravenous Immunoglobulins for Steroid-Refractory Esophageal Involvement Related to Polymyositis and Dermatomyositis: A Series of 73 Patients
I. Marie et al.
ARTHRITIS CARE & RESEARCH (2010)
Rituximab Therapy for Myopathy Associated With Anti-Signal Recognition Particle Antibodies: A Case Series
Ritu Valiyil et al.
ARTHRITIS CARE & RESEARCH (2010)
Dermatomyositis: A Clinicopathological Study of 40 Patients
Edward S. Smith et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2009)
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
Marinos C. Dalakas et al.
BRAIN (2009)
Treatment of Adult Inflammatory Myositis With Rituximab An Emerging Therapy for Refractory Patients
Shefali Majmudar et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
Evaluation and treatment of inflammatory myopathies
A. A. Amato et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis
Yuzo Suzuki et al.
LUNG (2009)
DERMATOMYOSITIS WITH INCLUSION BODY MYOSITIS PATHOLOGY
Robert Layzer et al.
MUSCLE & NERVE (2009)
Rituximab treatment of the anti-synthetase syndrome-a retrospective case series
Marthe Sem et al.
RHEUMATOLOGY (2009)
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M. Dastmalchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: A propensity score analysis
Roopa Seshadri et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate
G. J. D. Hengstman et al.
EUROPEAN NEUROLOGY (2008)
A pilot trial of rituximab in the treatment of patients with dermatomyositis
Lorinda Chung et al.
ARCHIVES OF DERMATOLOGY (2007)
Mycophenolate mofetil treatment in resistant myositis
C. N. Pisoni et al.
RHEUMATOLOGY (2007)
Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
Y. Yamasaki et al.
RHEUMATOLOGY (2007)
Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients
P. Efthimiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Pilot trial of etanercept in the treatment of inclusion-body myositis
RJ Barohn et al.
NEUROLOGY (2006)
The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids
AV Ramanan et al.
ARTHRITIS AND RHEUMATISM (2005)
Treatment of antisynthetase-associated interstitial lung disease with tacrolimus
MR Wilkes et al.
ARTHRITIS AND RHEUMATISM (2005)
Polymyositis/dermatomyositis and interstitial lung disease: A new therapeutic approach with T-cell-specific immunosuppressants
K Takada et al.
AUTOIMMUNITY (2005)
Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy
V Majithia et al.
RHEUMATOLOGY (2005)
Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety
P Riley et al.
RHEUMATOLOGY (2004)
International consensus on preliminary definitions of improvement in adult and juvenile myositis
LG Rider et al.
ARTHRITIS AND RHEUMATISM (2004)
Polymyositis and dermatomyositis
MC Dalakas et al.
LANCET (2003)
Polymyositis - An overdiagnosed entity
MFG van der Meulen et al.
NEUROLOGY (2003)
Anti-T-lymphocyte globulin treatment in inclusion body myositis - A randomized pilot study
C Lindberg et al.
NEUROLOGY (2003)
Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis - An open study with thirty-five adult patients
P Cherin et al.
ARTHRITIS AND RHEUMATISM (2002)
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo
UA Badrising et al.
ANNALS OF NEUROLOGY (2002)
A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM
MC Dalakas et al.
NEUROLOGY (2001)
Abnormal signal intensity in skeletal muscle at MR imaging: Patterns, pearls, and pitfalls
DA May et al.
RADIOGRAPHICS (2000)
High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study
MC Walter et al.
JOURNAL OF NEUROLOGY (2000)
Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis
J Vencovsky et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2000)
Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate
S Al-Mayouf et al.
CLINICAL RHEUMATOLOGY (2000)
分享论文
